Date Filed | Type | Description |
03/14/2023 |
4
| Klompas Neil A (President & COO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Sold 2,977 shares
@ $7.8259, valued at
$23.3k
Exercised 2,500 restricted stock units
@ $0 Exercised 2,708 restricted stock units
@ $0 |
|
01/06/2023 |
4
| Klompas Neil A (President & COO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 87,500 options to buy
@ $8, valued at
$700k
Granted 58,500 restricted stock units
@ $0 |
|
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/07/2022 |
4
| Klompas Neil A (COO & CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 277 shares
@ $13.94, valued at
$3.9k
|
|
07/08/2021 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 299 shares
@ $29.49, valued at
$8.8k
|
|
03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/11/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
01/11/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/11/2020 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Exercised 8,380 shares
@ $4.1945, valued at
$35.1k
Exercised 16,620 shares
@ $5.6708, valued at
$94.2k
Sold 25,000 shares
@ $53.2453, valued at
$1.3M
Exercised 8,380 options to buy
@ $0 Exercised 16,620 options to buy
@ $0 |
|
07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/11/2020 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 45,000 options to buy
@ $35.2, valued at
$1.6M
Granted 7,500 restricted stock units
@ $0 |
|
01/09/2020 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 394 shares
@ $19.54, valued at
$7.7k
|
|
07/10/2019 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 464 shares
@ $12.49, valued at
$5.8k
|
|
05/08/2019 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Exercised 6,704 shares
@ $2.66, valued at
$17.8k
Sold 6,704 shares
@ $19.2206, valued at
$128.9k
Exercised 8,380 shares
@ $3.53, valued at
$29.6k
Sold 1,604 shares
@ $19.2506, valued at
$30.9k
Exercised 6,704 options to buy
@ $0 Exercised 8,380 options to buy
@ $0 |
|
03/28/2019 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 15,000 options to buy
@ $15.23, valued at
$228.5k
|
|
01/10/2019 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 414 shares
@ $12.48, valued at
$5.2k
Granted 90,000 options to buy
@ $15.53, valued at
$1.4M
|
|
01/02/2019 |
3
| Klompas Neil A (CFO) has filed a Form 3 on Zymeworks Inc. |